4.6 Article

Synthesis and Investigation of Anti-Inflammatory Activity of New Thiourea Derivatives of Naproxen

Journal

PHARMACEUTICALS
Volume 16, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/ph16050666

Keywords

naproxen; thiourea; carrageenan; paw edema; anti-inflammatory activity; COX-2; 5-LOX; molecular docking; FRED

Ask authors/readers for more resources

The aim of the study was to synthesize and investigate the dose-dependent anti-inflammatory effect of new thiourea derivatives of naproxen with selected aromatic amines and esters of aromatic amino acids. The in vivo study demonstrated that derivatives of m-anisidine (4) and N-methyl tryptophan methyl ester (7) showed the most potent anti-inflammatory activity four hours after injection of carrageenan, with inhibition percentages of 54.01% and 54.12% respectively. In vitro assays of COX-2 inhibition indicated that none of the compounds tested achieved 50% inhibition at concentrations lower than 100 mu M. On the other hand, the aromatic amine derivatives (1-5) exhibited significant inhibition of 5-LOX, with compound 4 showing the lowest IC50 value of 0.30 mu M. Therefore, compound 4, with its high anti-edematous activity and potent inhibition of 5-LOX, holds promise as a potential anti-inflammatory agent.
The aim of the study was a synthesis and investigation of the dose-dependent antiinflammatory effect of new thiourea derivatives of naproxen with selected aromatic amines and esters of aromatic amino acids. The results of the in vivo study indicate that derivatives of m-anisidine (4) and N-methyl tryptophan methyl ester (7) showed the most potent anti-inflammatory activity four hours after injection of carrageenan, with the percentage of inhibition of 54.01% and 54.12%, respectively. In vitro assays of COX-2 inhibition demonstrated that none of the tested compounds achieved 50% inhibition at concentrations lower than 100 mu M. On the other hand, the aromatic amine derivatives (1-5) accomplished significant inhibition of 5-LOX, and the lowest IC50 value was observed for compound 4 (0.30 mu M). High anti-edematous activity of compound 4 in the rat paw edema model, together with potent inhibition of 5-LOX, highlight this compound as a promising anti-inflammatory agent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available